Afya (AFYA) Stock Price

Afya Price

NASDAQ·CLOSED
72.14
​
Market closed

Over the last 8 years Afya grew revenue by 39.7% annually, reaching 3.07 B BRL. Earnings per share have grown at 41.4% per year over the last 8 years. For Afya, the net margin of 24.0% is up versus 14.9% a few years ago. At today's price the dividend yield works out to roughly 0.32%. The payout ratio is around 14% of earnings. The consensus 12-month price target for Afya is 83.05 BRL, about 15.1% above where the stock trades today. Of 13 analysts, 1 rate the stock a buy — an overall Hold consensus.

Afya stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Afya business model & stock analysis

Afya Ltd is an emerging healthcare company that has established itself in Kenya. It was founded in 2012 by Dr. Jonathan D. Quick with the aim of improving the health of the Kenyan population. The story of Afya Ltd begins with the experiences that Dr. Quick gathered while working as a doctor in Kenya. While working in rural areas, he witnessed firsthand the challenges associated with limited access to quality healthcare. There was a lack of personnel, infrastructure, and medical expertise. Dr. Quick decided to take action against these issues and founded Afya Ltd. The business model of Afya Ltd is diverse. The company has multiple divisions that contribute to the goal of improving healthcare in Kenya. One of the main divisions of Afya Ltd is the provision of medical services. The company operates several clinics that cater to the needs of the local population, providing treatment and medical advice. Another area of Afya Ltd is the education and training of medical personnel. The company offers professional development opportunities for doctors, nurses, and other medical professionals to enhance their knowledge and skills. In this way, Afya Ltd contributes to improving the overall quality of medical care in Kenya. Afya Ltd is also involved in public health. The company supports various initiatives to prevent the spread of diseases and improve general hygiene in communities. This includes providing clean drinking water and educating people about diseases such as HIV/AIDS and malaria. An important part of Afya Ltd's offerings is medical products such as medicines, medical devices, and medical accessories. The company works closely with leading pharmaceutical companies and other suppliers to deliver high-quality products at reliable prices. Overall, Afya Ltd is a company that is fully committed to improving healthcare in Kenya. The various divisions of the company work closely together to offer a wide range of services, products, and programs tailored to the needs of the Kenyan population. With a strong commitment to excellence, innovation, and sustainability, Afya Ltd will undoubtedly play a significant role in shaping the future of healthcare in Kenya.

Frequently asked questions about Afya

Afya Ltd operates as a leading medical education group in Brazil. The company's business model primarily focuses on offering healthcare education solutions, including specialized courses, preparatory courses for medical residency exams, and continuing medical education programs. Afya Ltd also provides digital education products and services to medical students and healthcare professionals through its online platform. By merging technology and education, Afya aims to deliver high-quality medical education and enhance the careers of healthcare professionals. With a strong presence in Brazil, the company seeks to contribute to the transformation and improvement of the country's healthcare industry.

Afya Ltd primarily operates in the healthcare and education industries.

The main competitors of Afya Ltd in the market include companies like Cogna Educação, Estácio Participações, and YDUQS (formerly known as Estácio Participações). These companies also operate in the education sector, providing similar services and solutions.

Afya Ltd. is a leading medical education group based in Brazil. The company was founded in 1997 and has since become a major player in the healthcare education sector. Afya provides a wide range of educational programs and services, including undergraduate and graduate courses, continuing medical education, and preparatory courses for medical residency examinations. With a strong focus on medical, dentistry, and nursing education, Afya has established a solid reputation for delivering high-quality training and producing well-prepared healthcare professionals. The company has expanded both organically and through strategic acquisitions, positioning itself as a key player in the Brazilian healthcare education market.

Afya Ltd has achieved several significant milestones. The company successfully conducted its initial public offering (IPO) in July 2019, listing its shares on the Nasdaq Global Select Market under the ticker symbol "AFYA." Afya Ltd has also expanded its operations and presence by acquiring several educational institutions and healthcare companies, enhancing its market share and diversifying its revenue streams. Additionally, the company has implemented innovative technology in its educational platforms, enabling effective remote learning and increasing accessibility for students. Afya Ltd continues to demonstrate strong growth potential and remains committed to providing quality education and healthcare services.

Afya Ltd is primarily present in Brazil.

Afya Ltd represents a set of core values and corporate philosophy aimed at driving success and impact. The company's values include a strong commitment to education, providing high-quality, accessible, and technology-driven solutions in the Brazilian healthcare market. Afya Ltd focuses on fostering innovation, embracing diversity and inclusion, and promoting a culture of continuous learning among its stakeholders. With a dedication to excellence, transparency, and integrity, Afya Ltd strives to make a positive difference in the healthcare sector by improving medical education and healthcare delivery for the benefit of students, healthcare professionals, and patients alike.

Analysts currently set an average price target of 84.31 BRL for the Afya stock (median: 83.05 BRL), implying +16.9 % versus the latest price. The consensus is based on 13 analyst ratings.

13 analysts currently rate the Afya stock: 1 recommend buying, 7 holding and 5 selling. For 2026, analysts expect Afya to generate revenue of 4.16 B BRL and earnings per share of 9.48 BRL.

Converted at the current exchange rate, the Afya share trades at 12.73 EUR (72.14 BRL).

The Afya share (AFYA) is listed on 3 stock exchanges, including: NASDAQ (AFYA), Frankfurt (1AY.F), München (1AY.MU).

Afya Ltd is an African company specializing in providing healthcare services. The company is headquartered in Nairobi, Kenya and operates subsidiaries in Malawi, Uganda, Tanzania, and Zambia. Its core business includes providing healthcare services for people of all ages and genders, offering a wide range of services within the healthcare sector such as preventive health measures, specialized services for women and children, outpatient care for patients with chronic illnesses, and specialized services for HIV/AIDS patients. Afya Ltd is also involved in the production of medications and has a long-term business strategy focused on developing innovative solutions in telemedicine. The company operates a scalable business model and has both investor and government funding. It has established a strong presence in Africa and has provided healthcare services to thousands of individuals. Afya Ltd offers a broad range of healthcare services and medications to both the government and investors, and has long-term investment plans in telemedicine.

The expected revenue of Afya is 4.16 B BRL. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Afya is 862.90 M BRL. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Afya is currently 7.61. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Afya stock.

The price-to-sales ratio (P/S) of Afya is currently 1.58. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Afya stock.

The Eulerpool Quality Score for Afya is 5/10.

The ISIN of Afya is KYG011251066. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Afya is A2PM8D. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Afya is AFYA. The ticker symbol is used to trade Afya shares on the stock exchange.

Fair ValueTerminal
70.70 BRL
Over-/UndervaluationTerminal
Fairly valued
Industry
Diversified Consumer Services
Number of shares
Employees
Revenue per Employee
327,159.15 BRL
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website afya.com.br
Country
Brazil
Currency
BRL
Initial public offering
Jul 19, 2019
ISIN
KYG011251066
Cusip
G01125106
Sedol
BKF9D57
Market capitalization
6.59 B BRLMid Cap
52-Week Range
PEG
1.43
P/E ratio
P/Ee 2026
7.63
P/Ee 2027
6.82
P/Ee 2028
6.37
P/S
P/Se
1.58
EV/EBIT
4.42
P/B Ratio
1.36
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
9.26 %
Last updated Oct 16, 2026, 10:04 AM

Afya Ticker

FRANKFURT · 1AY.FMUNICH · 1AY.MUNASDAQ · AFYA

Afya FIGI

AFYA:US · BBG00PK9C4C7AFYA:UA · BBG00PK9C5H9AFYA:UC · BBG00PK9C5J7AFYA:UN · BBG00PK9C5L4AFYA:UP · BBG00PK9C5M3AFYA:UB · BBG00PK9C5P0AFYA:UM · BBG00PK9C5R8AFYA:UX · BBG00PK9C5S7AFYA:UD · BBG00PK9C5Y0AFYA:UW · BBG00PK9C605AFYA:UF · BBG00PK9C614AFYA:VY · BBG00PK9C623

All fundamentals and in-depth analysis of Afya

Our stock analysis for Afya stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Afya. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.